Though the two have similar symptoms, they require different ... July 17, 2023 — Chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, is on the rise worldwide.

Results of the AGAVE-201 trial demonstrate a high incidence of response to axatilimab among patients with chronic graft-versus-host disease.

In this randomized controlled trial, axatilimab effectively managed symptoms in patients with recurrent or refractory graft ...

Panelists discuss how axatilimab, a novel therapy for chronic graft-versus-host disease (cGVHD), functions through a unique mechanism of action compared to other treatments, highlighting its potential ...

Health Check is renowned biotech journo Tim Boreham’s daily wrap covering morning movers and shakers of note in the ASX ...

Mesoblast Limited (ASX:MSB) is developing innovative allogeneic cellular medicines to treat complex inflammatory diseases. The company’s portfolio of Phase 3 product candidates includes therapies for ...

New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease.

Buy the report here. The report also covers products from therapy areas such as Immunology, Dermatology, Oncology, and Gastrointestinal which include the indications Rheumatoid Arthritis, Graft Versus ...

In 2022 alone, 16.1 per cent or 20,322 medically certified deaths in Malaysia were due to coronary heart disease. Thanks to advancements in the medical field, procedures like coronary artery bypass ...

The conversion price of the convertible notes will be US$9.06 per ADR (American Depository Receipt) equivalent to A$1.32 per ASX-listed share, representing a 25% premium to Mesoblast’s 5-day volume ...

REGULATED INFORMATIONThe interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a ...

1 Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom 2 Strathclyde Institute of Pharmacy & Biomedical Sciences, ...